DUBLIN, Ireland — John Hendrickson, chief executive officer Perrigo Co. plc, plans to retire from the company after just over a year in the CEO role. Perrigo said late Monday that Hendrickson will remain with the company until his replacement is appointed and up to 60 days thereafter to assist with the transition. Plans call
DUBLIN, Ireland — Perrigo Co. plc has begun shipping a store-brand version of Women’s Rogaine, a foam hair regrowth treatment. Perrigo said it’s the first to market with an over-the-counter, private-label version of minoxidil topical aerosol foam 5%. The product is packaged and marketed as a store brand or retailer “own label brand and provides
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution 5 mg/1.5 mg per 5 ml. Hydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough in adults and children ages 6 and older. A combination medication, the
DUBLIN, Ireland — Perrigo Co. plc plans to acquire Geiss, Destin & Dunn Inc., a U.S. distributor of over-the-counter health care, personal care and consumer products. Financial terms of the deal weren’t disclosed. Perrigo said Wednesday that it expects to finalize the Geiss, Destin & Dunn (GDD) transaction by the end of August. Based in
DUBLIN, Ireland — Perrigo Co. plc has wrapped up the sale of its U.S. vitamins, minerals and supplements (VMS) business to International Vitamin Corp. (IVC). The cash deal, terms of which weren’t disclosed, was announced in late June. The VMS business was part of the Perrigo Nutritionals division, whose core products are store-brand infant formula
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for omeprazole and sodium bicarbonate capsules 20 mg/1100 mg, an over-the-counter medicine for heartburn. Perrigo said Monday that its product marks the first store-brand launch of an equivalent to Bayer’s Zegerid OTC capsules. Shipments to retail customers are under way,
DUBLIN, Ireland — Perrigo Co. plc plans to sell its U.S. vitamins, minerals and supplements (VMS) business to International Vitamin Corp. (IVC). Financial terms of the deal weren’t disclosed. Perrigo said Monday that the company had been looking to sell off its VMS business and that it expects the transaction to close by early August,
DUBLIN, Ireland — Perrigo Co. and Allergan plc have rolled out guaifenesin 1,200-mg and dextromethorphan HBr 60-mg extended-release tablets, a combination expectorant and cough suppressant. The companies said Tuesday that the product marks the first over-the-counter store-brand equivalent to Mucinex DM 1,200-mg ER tablets from Reckitt Benckiser (RB) for retail and wholesale customers. First shipments
NEW YORK — Joseph Papa has resigned as chairman and chief executive officer of Perrigo Co. plc to join Valeant Pharmaceuticals International Inc. as chairman and CEO. Valeant said Monday that Papa, 60, is slated to start at the company by early May. Papa will succeed J. Michael Pearson, who is expected to remain as
